Your browser doesn't support javascript.
loading
Efficacy, safety, and pharmacokinetics of simeprevir, daclatasvir, and ribavirin in patients with recurrent hepatitis C virus genotype 1b infection after orthotopic liver transplantation: The Phase II SATURN study.
Forns, Xavier; Berenguer, Marina; Herzer, Kerstin; Sterneck, Martina; Donato, Maria Francesca; Andreone, Pietro; Fagiuoli, Stefano; Cieciura, Tomasz; Durlik, Magdalena; Calleja, Jose Luis; Mariño, Zoe; Shukla, Umesh; Verbinnen, Thierry; Lenz, Oliver; Ouwerkerk-Mahadevan, Sivi; Peeters, Monika; Janssen, Katrien; Kalmeijer, Ronald; Jessner, Wolfgang.
Afiliación
  • Forns X; Liver Unit, Hospital Clinic, IDIBAPS and CIBEREHD, University of Barcelona, Barcelona, Spain.
  • Berenguer M; Department of Digestive Diseases, Hepatology and Liver Transplantation Unit, La Fe University Hospital and CIBEREHD, Valencia, Spain.
  • Herzer K; Department of General, Visceral and Transplantation Surgery and Department of Gastroenterology and Hepatology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
  • Sterneck M; Department of Hepatobiliary and Transplant Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Donato MF; Division of Digestive Diseases, IRCCS Maggiore Hospital, Milan, Italy.
  • Andreone P; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
  • Fagiuoli S; Gastroenterology and Transplant Hepatology, Papa Giovanni XXIII Hospital, Bergamo, Italy.
  • Cieciura T; Department of Immunology, Transplant Medicine and Internal Diseases, Transplantation Institute, Medical University of Warsaw, Warsaw, Poland.
  • Durlik M; Department of Transplantation Medicine and Nephrology, Transplantation Institute, Medical University of Warsaw, Warsaw, Poland.
  • Calleja JL; Liver Unit, Hospital Universitario Puerta de Hierro, CIBEREHD and IDIPHIM, Madrid, Spain.
  • Mariño Z; Liver Unit, Hospital Clinic, IDIBAPS and CIBEREHD, University of Barcelona, Barcelona, Spain.
  • Shukla U; Janssen Research & Development, LLC, Titusville, NJ, USA.
  • Verbinnen T; Janssen Pharmaceutica NV, Beerse, Belgium.
  • Lenz O; Janssen Pharmaceutica NV, Beerse, Belgium.
  • Ouwerkerk-Mahadevan S; Janssen Research & Development, Beerse, Belgium.
  • Peeters M; Janssen Pharmaceutica NV, Beerse, Belgium.
  • Janssen K; Janssen Pharmaceutica NV, Beerse, Belgium.
  • Kalmeijer R; Janssen Research & Development, LLC, Titusville, NJ, USA.
  • Jessner W; Janssen Research & Development, LLC, Titusville, NJ, USA.
Transpl Infect Dis ; 19(3)2017 06.
Article en En | MEDLINE | ID: mdl-28295849
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Antivirales / Trasplante de Hígado / Hepacivirus / Hepatitis C Crónica / Inmunosupresores Tipo de estudio: Clinical_trials Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Transpl Infect Dis Asunto de la revista: TRANSPLANTE Año: 2017 Tipo del documento: Article País de afiliación: España
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Antivirales / Trasplante de Hígado / Hepacivirus / Hepatitis C Crónica / Inmunosupresores Tipo de estudio: Clinical_trials Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Transpl Infect Dis Asunto de la revista: TRANSPLANTE Año: 2017 Tipo del documento: Article País de afiliación: España